Trials / Completed
CompletedNCT01591434
Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers
An Open Randomised Comparative Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- ConvaTec Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Based upon the in-vitro data AQUACEL® Extra™ achieves a 39% increase in absorbency. As such it is anticipated that through improved exudate management a longer wear time will be achieved in the AQUACEL® Extra™ group compared to AQUACEL® in the management of chronic wounds such as venous leg ulcers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AQUACEL® | Dressing to be changed as clinically needed or at least every seven days. |
| DEVICE | AQUACEL® Extra™ | Dressing to be changed as clinically needed or at least every seven days. |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2012-05-04
- Last updated
- 2013-07-30
Locations
12 sites across 4 countries: Germany, Netherlands, Poland, United Kingdom
Source: ClinicalTrials.gov record NCT01591434. Inclusion in this directory is not an endorsement.